Single high-dose etoposide and melphalan with non-cryopreserved autologous marrow rescue as primary therapy for relapsed, refractory and poor-prognosis Hodgkin's disease.

A simplified schedule of high-dose chemotherapy (HDC) consisting of melphalan (140 mg m-2) plus VP16 (2.5 g m-2) given over 12-18 h together with autologous non-cryopreserved autologous bone marrow transplant (ABMT) was used for treatment of relapsed (37 patients) and refractory (seven patients) pat...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Seymour, L. K., Dansey, R. D., Bezwoda, W. R.
Formáid: Artigo
Teanga:Inglês
Foilsithe: Nature Publishing Group 1994
Ábhair:
Research Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033336/
https://ncbi.nlm.nih.gov/pubmed/8080741
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla